Breast implant makers vie for customers amid Allergan recall

Nearly three months after FDA said scientific data didn't support a ban on any breast implants, it reversed course and cited new evidence when it asked Allergan to voluntarily recall nearly a dozen different macrotextured products linked to cases of a type of non-Hodgkin's lymphoma.